Dealmakers weekly review – July 24 2012 – GSK, Human Genome Sciences, Fenwal, Par, One Lambda, TPG Capital, Fresenius Kabi, Thermo Fisher
05:31 EDT 24 Jul 2012 | Current Partnering
M&A takes off with mega deals for Human Genome Sciences, Fenwal, Par Pharmaceuticals and One Lambda The review Partnering was busy in the past week, but there were no significant headline value deals announced. The higest deal of the week was the grant award of $186 million for the development of an AIDS vaccine in [...]The post Dealmakers weekly review – July 24 2012 – GSK, Human Genome Sciences, Fenwal, Par, One Lambda, TPG Capital, Fresenius Kabi, Thermo Fisher appeared first on Curre..
Original Article: Dealmakers weekly review – July 24 2012 – GSK, Human Genome Sciences, Fenwal, Par, One Lambda, TPG Capital, Fresenius Kabi, Thermo Fisher
More From BioPortfolio on "Dealmakers weekly review – July 24 2012 – GSK, Human Genome Sciences, Fenwal, Par, One Lambda, TPG Capital, Fresenius Kabi, Thermo Fisher"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
